Change report.
Japan Tobacco: Corrected Issuance Registration Form
Japan Tobacco: Extraordinary Report
Japan Tobacco: 2025 First Quarter Results (CFO Presentation)
Japan Tobacco: Earnings Conference materials for the 1st quarter of fiscal year 2025 (CFO presentation)
Japan Tobacco: Consolidated Financial Results for the Three Months Ended March 31,2025 <under IFRS>
Japan Tobacco: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] (consolidated)
Japan Tobacco: Notice of Change in Consolidated Subsidiary (Transfer of Subsidiary Shares)
Japan Tobacco: Notice regarding the transfer of JT Group’s Pharmaceutical Business through a company simplified absorption-type split
Japan Tobacco: Notice regarding changes in consolidated subsidiaries (transfer of subsidiary shares)
Japan Tobacco: Notice regarding succession of our pharmaceutical business to Shionogi Pharmaceutical Co., Ltd. through a company split (simple absorption split)
Japan Tobacco: Notice Concerning Issuance of Senior Notes by JT and JT's Subsidiary
Japan Tobacco: Notice regarding the issuance of ordinary corporate bonds by the Company and its overseas subsidiaries
Japan Tobacco: Notice Concerning Issuance of 18th and 19th Series Straight Bonds
Japan Tobacco: Notice regarding issuance of 18th corporate bonds and 19th corporate bonds (with general collateral)
Japan Tobacco: Issuance registration supplementary documents (stock certificates, Bonds, etc.)
Japan Tobacco: Corrected Issuance Registration Form
Japan Tobacco: Extraordinary Report
Japan Tobacco: Corporate Governance Report
Japan Tobacco: Corporate Governance Report 2025/03/26